ABUS vs MOS · P/E 5.4, rev $6.2M vs P/E 161, rev $11.12B
Arbutus Biopharma Corp (ABUS) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the ABUS and MOS stock pages for the full models.
Not investment advice.